WHO naming stem · anywhere in the name · 187 listed names
vir
This page was written with AI.
antivirals (undefined group)
Where it sits in a name
WHO writes the stem as vir, without hyphens, which means it can sit anywhere in a name. So the letters vir sit anywhere in the name (vir).
All 187 names WHO lists under vir
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 57 of 187 names appear in these lists: 57 in the US list (FDA Drugs@FDA) and 48 in the EU central list (EMA); 29 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- abacavirUS brands: ZIAGENin combination: TRIUMEQ with dolutegravir + lamivudine; TRIUMEQ PD with dolutegravir + lamivudine; EPZICOM (discontinued in FDA listings) with lamivudine; TRIZIVIR (discontinued in FDA listings) with lamivudine + zidovudineEU (central) brands: Ziagen
- abimtrelvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- aciclovirFDA writes it ACYCLOVIREU (central) brands: none found
- adafosbuvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- adefovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- afovirsenNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- alamifovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- alisporivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- alvircept sudotoxNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- amdoxovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- amenamevirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- amitivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- amlivirsenNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- amprenavir
- aplavirocNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- asunaprevirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- atazanavirUS brands: REYATAZ
- atevirdineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- balapiravirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- baloxavir marboxilUS brands: XOFLUZAEU (central) brands: Xofluza
- beclabuvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bemnifosbuvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bepirovirsenNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- besifovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bevirimatNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- boceprevir
- bofutrelvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- brecanavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- buciclovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- canocapavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- celgosivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cenicrivirocNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cidofovir
- ciluprevirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- claficapavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- coblopasvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- daclatasvir
- danoprevirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dapivirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- darunavirUS brands: PREZISTA
- dasabuvirUS brands, in combination: VIEKIRA PAK (COPACKAGED) (discontinued in FDA listings) with ombitasvir + paritaprevir + ritonavir; VIEKIRA XR (discontinued in FDA listings) with ombitasvir + paritaprevir + ritonavir
- delavirdineEU (central) brands: none found
- deldeprevirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- deleobuvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- denotivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- depulfavirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- desciclovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- detiviciclovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- doravirineUS brands: PIFELTROEU (central) brands: Pifeltro
- droxinavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- efavirenzin combination: SYMFI with lamivudine + tenofovir disoproxil; ATRIPLA (discontinued in FDA listings) with emtricitabine + tenofovir disoproxil; SYMFI LO (discontinued in FDA listings) with lamivudine + tenofovir disoproxilin combination: Efavirenz/Emtricitabine/Tenofovir disoproxil Krka with emtricitabine + tenofovir disoproxil; Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan with emtricitabine + tenofovir disoproxil; Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva with emtricitabine + tenofovir disoproxil; Atripla (withdrawn) with emtricitabine + tenofovir disoproxil
- elbasvir
- elsulfavirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- elunonavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- emivirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enfuvirtideEU (central) brands: Fuzeon
- ensitrelvirUS brands: XOCOVAEU (central) brands: Zokovea
- entecavirUS brands: BARACLUDE
- enviradeneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enviroximeNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enzaplatovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- eprociclovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- etravirineUS brands: INTELENCEEU (central) brands: Intelence
- faldaprevirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- famciclovirEU (central) brands: none found
- favipiravirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- filibuvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- filociclovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fipravirimatNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- firzacorvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fomivirsen
- fosamprenavir
- fosdevirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fostemsavirUS brands: RUKOBIAEU (central) brands: Rukobia
- furaprevirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- galidesivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ganciclovirUS brands: ZIRGAN, CYTOVENE (discontinued in FDA listings), GANZYK-RTU (discontinued in FDA listings), VITRASERT (discontinued in FDA listings)
- glecaprevir
- grazoprevir
- inarigivir soproxilNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- indinavir
- islatravirEU (central) brands: none found
- lagociclovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lagociclovir valactateNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- laninamivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lasinavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ledipasvirEU (central) brands: none found
- lenacapavirin combination: BIXLENVO with bictegravir; BIXLENVO SUNLENCA STARTER PACK (COPACKAGED) with bictegravir
- lersivirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- letermovirUS brands: PREVYMISEU (central) brands: Prevymis
- linvencorvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- litomeglovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lobucavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lomibuvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lopinavirEU (central) brands, in combination: Kaletra with ritonavir; Lopinavir/Ritonavir Viatris with ritonavir
- lovirideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lufotrelvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- maravirocUS brands: SELZENTRYEU (central) brands: Celsentri
- maribavirUS brands: LIVTENCITYEU (central) brands: Livtencity
- mindeudesivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- miravirsenNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- molnupiravirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mozenavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- narlaprevirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nelfinavirUS brands: VIRACEPT
- neracorvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nesbuvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nevirapine
- nirmatrelvir
- obeldesivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- odalasvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- omaciclovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ombitasvirUS brands, in combination: TECHNIVIE (discontinued in FDA listings) with paritaprevir + ritonavir; VIEKIRA PAK (COPACKAGED) (discontinued in FDA listings) with dasabuvir + paritaprevir + ritonavir; VIEKIRA XR (discontinued in FDA listings) with dasabuvir + paritaprevir + ritonavir
- onradivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- opaviralineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- oseltamivirUS brands: TAMIFLU
- palinavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- paritaprevirUS brands, in combination: TECHNIVIE (discontinued in FDA listings) with ombitasvir + ritonavir; VIEKIRA PAK (COPACKAGED) (discontinued in FDA listings) with dasabuvir + ombitasvir + ritonavir; VIEKIRA XR (discontinued in FDA listings) with dasabuvir + ombitasvir + ritonavir
- penciclovirUS brands: DENAVIREU (central) brands: none found
- pepirovirsenNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- peramivirUS brands: RAPIVAB
- pibrentasvir
- pimodivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pirodavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pocapavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pomotrelvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pradefovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- presatovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pritelivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- radalbuvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- radavirsenNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ravidasvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- remdesivirUS brands: VEKLURYEU (central) brands: Veklury
- riamilovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ribavirinUS brands: COPEGUS (discontinued in FDA listings), REBETOL (discontinued in FDA listings), RIBASPHERE (discontinued in FDA listings), VIRAZOLE (discontinued in FDA listings)EU (central) brands: Cotronak (withdrawn), Rebetol (withdrawn), Ribavirin BioPartners (lapsed), Ribavirin Mylan (withdrawn), Ribavirin Teva (withdrawn), Ribavirin Teva Pharma B.V. (withdrawn)
- rilematovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rilpivirinein combination: CABENUVA KIT with cabotegravir; COMPLERA with emtricitabine + tenofovir disoproxil; JULUCA with dolutegravir; ODEFSEY with emtricitabine + tenofovir alafenamidein combination: Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris with emtricitabine + tenofovir alafenamide; Eviplera with emtricitabine + tenofovir disoproxil; Juluca with dolutegravir; Odefsey with emtricitabine + tenofovir alafenamide
- ritonavirUS brands: NORVIRin combination: KALETRA with lopinavir; PAXLOVID (COPACKAGED) with nirmatrelvir; TECHNIVIE (discontinued in FDA listings) with ombitasvir + paritaprevir; VIEKIRA PAK (COPACKAGED) (discontinued in FDA listings) with dasabuvir + ombitasvir + paritaprevir; VIEKIRA XR (discontinued in FDA listings) with dasabuvir + ombitasvir + paritaprevirin combination: Kaletra with lopinavir; Lopinavir/Ritonavir Viatris with lopinavir; Paxlovid with nirmatrelvir; Viekirax (withdrawn) with ombitasvir + paritaprevir
- rociclovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rovafovir etalafenamideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rupintrivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ruzasvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- samatasvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- saquinavir
- setrobuvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- simaprevirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sisunatrovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sofosbuvirUS brands: SOVALDIin combination: EPCLUSA with velpatasvir; HARVONI with ledipasvir; VOSEVI with velpatasvir + voxilaprevirEU (central) brands: Sovaldi
- sovaprevirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- talviralineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- taribavirinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tecovirimatUS brands: TPOXXEU (central) brands: Tecovirimat SIGA
- tegobuvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- telaprevir
- telinavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- temavirsenNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- temsavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tenofovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tenofovir alafenamideUS brands: VEMLIDYin combination: BIKTARVY with bictegravir + emtricitabine; DESCOVY with emtricitabine; GENVOYA with cobicistat + elvitegravir + emtricitabine; ODEFSEY with emtricitabine + rilpivirine; SYMTUZA with cobicistat + darunavir + emtricitabineEU (central) brands: Vemlidyin combination: Biktarvy with bictegravir + emtricitabine; Descovy with emtricitabine; Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris with emtricitabine + rilpivirine; Emtricitabine / Tenofovir alafenamide Viatris with emtricitabine; Genvoya with cobicistat + elvitegravir + emtricitabine; Odefsey with emtricitabine + rilpivirine; Symtuza with cobicistat + darunavir + emtricitabine
- tenofovir amibufenamideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tenofovir exalidexNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- teslexivirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tifuvirtideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tipranavirUS brands: APTIVUSEU (central) brands: Aptivus
- tiviciclovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tivirapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tomeglovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- trecovirsenNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- trovirdineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ulonivirineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- umifenovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- uprifosbuvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- valaciclovirUS brands: VALTREXFDA writes it VALACYCLOVIREU (central) brands: none found
- valganciclovirUS brands: VALCYTEEU (central) brands: none found
- valomaciclovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vaniprevirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vapendavirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vebicorvirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- vedroprevirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- velpatasvir
- vicrivirocNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- viroximeNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- voxilaprevirEU (central) brands: none found
- zanamivirUS brands: RELENZAEU (central) brands: Dectova
- zegruvirimatNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zinviroximeNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ziresovirNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Decode another name
Decoded
amitivir
Listed INNCarries the WHO stem vir
- virend of the nameWHO lists it hereWHO definition: antivirals (undefined group)
“amitivir” is an INN that WHO lists under vir in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of vir (Part II B) and the 187 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.